Cargando…
Amikacin Concentrations Predictive of Ototoxicity in Multidrug-Resistant Tuberculosis Patients
Aminoglycosides, such as amikacin, are used to treat multidrug-resistant tuberculosis. However, ototoxicity is a common problem and is monitored using peak and trough amikacin concentrations based on World Health Organization recommendations. Our objective was to identify clinical factors predictive...
Autores principales: | Modongo, Chawangwa, Pasipanodya, Jotam G., Zetola, Nicola M., Williams, Scott M., Sirugo, Giorgio, Gumbo, Tawanda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4576092/ https://www.ncbi.nlm.nih.gov/pubmed/26248372 http://dx.doi.org/10.1128/AAC.01050-15 |
Ejemplares similares
-
Artificial Intelligence and Amikacin Exposures Predictive of Outcomes in Multidrug-Resistant Tuberculosis Patients
por: Modongo, Chawangwa, et al.
Publicado: (2016) -
Amikacin Optimal Exposure Targets in the Hollow-Fiber System Model of Tuberculosis
por: Srivastava, Shashikant, et al.
Publicado: (2016) -
Successful MDR-TB treatment regimens including Amikacin are associated with high rates of hearing loss
por: Modongo, Chawangwa, et al.
Publicado: (2014) -
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation
por: Vinnard, Christopher, et al.
Publicado: (2017) -
Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis
por: Deshpande, Devyani, et al.
Publicado: (2018)